NCT04478084View on ClinicalTrials.gov

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland

PHASE3CompletedINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

March 19, 2022

Study Completion Date

July 21, 2022

Conditions
Rabies (Healthy Volunteers)
Interventions
BIOLOGICAL

Purified vero rabies vaccine - serum free VRVg-2

Pharmaceutical form:freeze-dried Route of administration: intradermal

BIOLOGICAL

Purified inactivated rabies vaccine

Pharmaceutical form:freeze-dried Route of administration: intradermal

BIOLOGICAL

Equine rabies immunoglobulins (ERIG) (only Group 3 and Group 4)

Pharmaceutical form: liquid/solution in 5 mL vials Route of administration: intramuscular

BIOLOGICAL

Human rabies immunoglobulins (HRIG) (only Group 5 and Group 6)

Pharmaceutical form: liquid/solution in 2 mL vials Route of administration: intramuscular

Trial Locations (3)

10400

Investigational Site Number :7640004, Bangkok

40002

Investigational Site Number :7640003, Khon Kaen

Unknown

Investigational Site Number :7640002, Bangkok

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT04478084 - Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland | Biotech Hunter | Biotech Hunter